The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Interstitial Lung Disease (ILD) Market Research Report 2025
Synopsis
Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.
The global Interstitial Lung Disease (ILD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interstitial Lung Disease (ILD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interstitial Lung Disease (ILD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Interstitial Lung Disease (ILD) in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Interstitial Lung Disease (ILD) include Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck and Siemens Healthineers, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interstitial Lung Disease (ILD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interstitial Lung Disease (ILD).
Report Scope
The Interstitial Lung Disease (ILD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interstitial Lung Disease (ILD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interstitial Lung Disease (ILD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Bellerophon Therapeutics, Inc
Bayer
Fujirebio (Miraca)
Philips
Merck
Siemens Healthineers
Segment by Type
Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Nonspecific Interstitial Pneumonitis
Hypersensitivity Pneumonitis
Cryptogenic Organizing Pneumonia
Acute Interstitial Pneumonitis
Desquamative Interstitial Pneumonitis
Others
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interstitial Lung Disease (ILD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.
The global Interstitial Lung Disease (ILD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interstitial Lung Disease (ILD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interstitial Lung Disease (ILD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Interstitial Lung Disease (ILD) in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Interstitial Lung Disease (ILD) include Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck and Siemens Healthineers, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interstitial Lung Disease (ILD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interstitial Lung Disease (ILD).
Report Scope
The Interstitial Lung Disease (ILD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interstitial Lung Disease (ILD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interstitial Lung Disease (ILD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Bellerophon Therapeutics, Inc
Bayer
Fujirebio (Miraca)
Philips
Merck
Siemens Healthineers
Segment by Type
Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Nonspecific Interstitial Pneumonitis
Hypersensitivity Pneumonitis
Cryptogenic Organizing Pneumonia
Acute Interstitial Pneumonitis
Desquamative Interstitial Pneumonitis
Others
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interstitial Lung Disease (ILD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interstitial Lung Disease (ILD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Interstitial Pneumonia
1.2.3 Idiopathic Pulmonary Fibrosis
1.2.4 Nonspecific Interstitial Pneumonitis
1.2.5 Hypersensitivity Pneumonitis
1.2.6 Cryptogenic Organizing Pneumonia
1.2.7 Acute Interstitial Pneumonitis
1.2.8 Desquamative Interstitial Pneumonitis
1.2.9 Others
1.3 Market by Application
1.3.1 Global Interstitial Lung Disease (ILD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interstitial Lung Disease (ILD) Market Perspective (2019-2030)
2.2 Interstitial Lung Disease (ILD) Growth Trends by Region
2.2.1 Global Interstitial Lung Disease (ILD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Interstitial Lung Disease (ILD) Historic Market Size by Region (2019-2024)
2.2.3 Interstitial Lung Disease (ILD) Forecasted Market Size by Region (2025-2030)
2.3 Interstitial Lung Disease (ILD) Market Dynamics
2.3.1 Interstitial Lung Disease (ILD) Industry Trends
2.3.2 Interstitial Lung Disease (ILD) Market Drivers
2.3.3 Interstitial Lung Disease (ILD) Market Challenges
2.3.4 Interstitial Lung Disease (ILD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interstitial Lung Disease (ILD) Players by Revenue
3.1.1 Global Top Interstitial Lung Disease (ILD) Players by Revenue (2019-2024)
3.1.2 Global Interstitial Lung Disease (ILD) Revenue Market Share by Players (2019-2024)
3.2 Global Interstitial Lung Disease (ILD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interstitial Lung Disease (ILD) Revenue
3.4 Global Interstitial Lung Disease (ILD) Market Concentration Ratio
3.4.1 Global Interstitial Lung Disease (ILD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interstitial Lung Disease (ILD) Revenue in 2023
3.5 Interstitial Lung Disease (ILD) Key Players Head office and Area Served
3.6 Key Players Interstitial Lung Disease (ILD) Product Solution and Service
3.7 Date of Enter into Interstitial Lung Disease (ILD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interstitial Lung Disease (ILD) Breakdown Data by Type
4.1 Global Interstitial Lung Disease (ILD) Historic Market Size by Type (2019-2024)
4.2 Global Interstitial Lung Disease (ILD) Forecasted Market Size by Type (2025-2030)
5 Interstitial Lung Disease (ILD) Breakdown Data by Application
5.1 Global Interstitial Lung Disease (ILD) Historic Market Size by Application (2019-2024)
5.2 Global Interstitial Lung Disease (ILD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Interstitial Lung Disease (ILD) Market Size (2019-2030)
6.2 North America Interstitial Lung Disease (ILD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Interstitial Lung Disease (ILD) Market Size by Country (2019-2024)
6.4 North America Interstitial Lung Disease (ILD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interstitial Lung Disease (ILD) Market Size (2019-2030)
7.2 Europe Interstitial Lung Disease (ILD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Interstitial Lung Disease (ILD) Market Size by Country (2019-2024)
7.4 Europe Interstitial Lung Disease (ILD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interstitial Lung Disease (ILD) Market Size (2019-2030)
8.2 Asia-Pacific Interstitial Lung Disease (ILD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interstitial Lung Disease (ILD) Market Size (2019-2030)
9.2 Latin America Interstitial Lung Disease (ILD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Interstitial Lung Disease (ILD) Market Size by Country (2019-2024)
9.4 Latin America Interstitial Lung Disease (ILD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interstitial Lung Disease (ILD) Market Size (2019-2030)
10.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Interstitial Lung Disease (ILD) Introduction
11.1.4 Boehringer Ingelheim Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bellerophon Therapeutics, Inc
11.2.1 Bellerophon Therapeutics, Inc Company Detail
11.2.2 Bellerophon Therapeutics, Inc Business Overview
11.2.3 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Introduction
11.2.4 Bellerophon Therapeutics, Inc Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.2.5 Bellerophon Therapeutics, Inc Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Interstitial Lung Disease (ILD) Introduction
11.3.4 Bayer Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Fujirebio (Miraca)
11.4.1 Fujirebio (Miraca) Company Detail
11.4.2 Fujirebio (Miraca) Business Overview
11.4.3 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Introduction
11.4.4 Fujirebio (Miraca) Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.4.5 Fujirebio (Miraca) Recent Development
11.5 Philips
11.5.1 Philips Company Detail
11.5.2 Philips Business Overview
11.5.3 Philips Interstitial Lung Disease (ILD) Introduction
11.5.4 Philips Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.5.5 Philips Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Interstitial Lung Disease (ILD) Introduction
11.6.4 Merck Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Siemens Healthineers
11.7.1 Siemens Healthineers Company Detail
11.7.2 Siemens Healthineers Business Overview
11.7.3 Siemens Healthineers Interstitial Lung Disease (ILD) Introduction
11.7.4 Siemens Healthineers Revenue in Interstitial Lung Disease (ILD) Business (2019-2024)
11.7.5 Siemens Healthineers Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Interstitial Lung Disease (ILD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Interstitial Pneumonia
Table 3. Key Players of Idiopathic Pulmonary Fibrosis
Table 4. Key Players of Nonspecific Interstitial Pneumonitis
Table 5. Key Players of Hypersensitivity Pneumonitis
Table 6. Key Players of Cryptogenic Organizing Pneumonia
Table 7. Key Players of Acute Interstitial Pneumonitis
Table 8. Key Players of Desquamative Interstitial Pneumonitis
Table 9. Key Players of Others
Table 10. Global Interstitial Lung Disease (ILD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Interstitial Lung Disease (ILD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Interstitial Lung Disease (ILD) Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Interstitial Lung Disease (ILD) Market Share by Region (2019-2024)
Table 14. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Interstitial Lung Disease (ILD) Market Share by Region (2025-2030)
Table 16. Interstitial Lung Disease (ILD) Market Trends
Table 17. Interstitial Lung Disease (ILD) Market Drivers
Table 18. Interstitial Lung Disease (ILD) Market Challenges
Table 19. Interstitial Lung Disease (ILD) Market Restraints
Table 20. Global Interstitial Lung Disease (ILD) Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Interstitial Lung Disease (ILD) Market Share by Players (2019-2024)
Table 22. Global Top Interstitial Lung Disease (ILD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interstitial Lung Disease (ILD) as of 2023)
Table 23. Ranking of Global Top Interstitial Lung Disease (ILD) Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Interstitial Lung Disease (ILD) Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Interstitial Lung Disease (ILD) Product Solution and Service
Table 27. Date of Enter into Interstitial Lung Disease (ILD) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Interstitial Lung Disease (ILD) Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2019-2024)
Table 31. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2025-2030)
Table 33. Global Interstitial Lung Disease (ILD) Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Interstitial Lung Disease (ILD) Revenue Market Share by Application (2019-2024)
Table 35. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Interstitial Lung Disease (ILD) Revenue Market Share by Application (2025-2030)
Table 37. North America Interstitial Lung Disease (ILD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Interstitial Lung Disease (ILD) Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Interstitial Lung Disease (ILD) Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Interstitial Lung Disease (ILD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Interstitial Lung Disease (ILD) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Interstitial Lung Disease (ILD) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Interstitial Lung Disease (ILD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Interstitial Lung Disease (ILD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Interstitial Lung Disease (ILD) Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Interstitial Lung Disease (ILD) Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Interstitial Lung Disease (ILD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2025-2030) & (US$ Million)
Table 52. Boehringer Ingelheim Company Detail
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Interstitial Lung Disease (ILD) Product
Table 55. Boehringer Ingelheim Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. Bellerophon Therapeutics, Inc Company Detail
Table 58. Bellerophon Therapeutics, Inc Business Overview
Table 59. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product
Table 60. Bellerophon Therapeutics, Inc Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 61. Bellerophon Therapeutics, Inc Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Interstitial Lung Disease (ILD) Product
Table 65. Bayer Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Fujirebio (Miraca) Company Detail
Table 68. Fujirebio (Miraca) Business Overview
Table 69. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product
Table 70. Fujirebio (Miraca) Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 71. Fujirebio (Miraca) Recent Development
Table 72. Philips Company Detail
Table 73. Philips Business Overview
Table 74. Philips Interstitial Lung Disease (ILD) Product
Table 75. Philips Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 76. Philips Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Interstitial Lung Disease (ILD) Product
Table 80. Merck Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Siemens Healthineers Company Detail
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers Interstitial Lung Disease (ILD) Product
Table 85. Siemens Healthineers Revenue in Interstitial Lung Disease (ILD) Business (2019-2024) & (US$ Million)
Table 86. Siemens Healthineers Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interstitial Lung Disease (ILD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Interstitial Lung Disease (ILD) Market Share by Type: 2023 VS 2030
Figure 3. Interstitial Pneumonia Features
Figure 4. Idiopathic Pulmonary Fibrosis Features
Figure 5. Nonspecific Interstitial Pneumonitis Features
Figure 6. Hypersensitivity Pneumonitis Features
Figure 7. Cryptogenic Organizing Pneumonia Features
Figure 8. Acute Interstitial Pneumonitis Features
Figure 9. Desquamative Interstitial Pneumonitis Features
Figure 10. Others Features
Figure 11. Global Interstitial Lung Disease (ILD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Interstitial Lung Disease (ILD) Market Share by Application: 2023 VS 2030
Figure 13. Adults Case Studies
Figure 14. Children Case Studies
Figure 15. Interstitial Lung Disease (ILD) Report Years Considered
Figure 16. Global Interstitial Lung Disease (ILD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Interstitial Lung Disease (ILD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Interstitial Lung Disease (ILD) Market Share by Region: 2023 VS 2030
Figure 19. Global Interstitial Lung Disease (ILD) Market Share by Players in 2023
Figure 20. Global Top Interstitial Lung Disease (ILD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interstitial Lung Disease (ILD) as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Interstitial Lung Disease (ILD) Revenue in 2023
Figure 22. North America Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Interstitial Lung Disease (ILD) Market Share by Country (2019-2030)
Figure 24. United States Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Interstitial Lung Disease (ILD) Market Share by Country (2019-2030)
Figure 28. Germany Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Interstitial Lung Disease (ILD) Market Share by Region (2019-2030)
Figure 36. China Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Interstitial Lung Disease (ILD) Market Share by Country (2019-2030)
Figure 44. Mexico Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Interstitial Lung Disease (ILD) Market Share by Country (2019-2030)
Figure 48. Turkey Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Interstitial Lung Disease (ILD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 51. Bellerophon Therapeutics, Inc Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 52. Bayer Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 53. Fujirebio (Miraca) Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 54. Philips Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 56. Siemens Healthineers Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
